Staar Surgical Co. (NASDAQ:STAA)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $9.47 and last traded at $9.45, with a volume of 126,593 shares changing hands. The stock had previously closed at $8.89.

Several equities analysts recently issued reports on the stock. Benchmark Co. raised shares of Staar Surgical from a “hold” rating to a “buy” rating and set a $6.00 price objective on the stock in a research note on Wednesday, May 18th. Stephens downgraded shares of Staar Surgical from an “overweight” rating to an “equal weight” rating in a research note on Thursday, May 12th. Zacks Investment Research raised shares of Staar Surgical from a “strong sell” rating to a “hold” rating in a research note on Wednesday, July 13th. Canaccord Genuity reissued a “hold” rating and set a $7.00 price objective on shares of Staar Surgical in a research note on Thursday, May 12th. Finally, William Blair reissued a “market perform” rating on shares of Staar Surgical in a research note on Thursday, August 4th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Staar Surgical presently has an average rating of “Hold” and a consensus target price of $7.50.

The firm has a 50-day moving average price of $6.64 and a 200-day moving average price of $6.63. The company’s market cap is $369.54 million.

Staar Surgical (NASDAQ:STAA) last released its quarterly earnings results on Wednesday, August 3rd. The company reported ($0.05) EPS for the quarter, hitting analysts’ consensus estimates of ($0.05). The company had revenue of $21 million for the quarter, compared to the consensus estimate of $19.88 million. The business’s revenue for the quarter was up 12.4% on a year-over-year basis. On average, analysts expect that Staar Surgical Co. will post ($0.31) EPS for the current year.

In other Staar Surgical news, major shareholder Broadwood Partners Lp acquired 14,144 shares of the stock in a transaction dated Wednesday, June 29th. The shares were bought at an average price of $5.24 per share, with a total value of $74,114.56. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Richard A. Meier sold 25,000 shares of Staar Surgical stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $5.35, for a total transaction of $133,750.00. Following the completion of the transaction, the director now directly owns 27,149 shares in the company, valued at approximately $145,247.15. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Staar Surgical stock. Mutual of America Capital Management LLC raised its stake in Staar Surgical Co. (NASDAQ:STAA) by 0.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 216,682 shares of the company’s stock after buying an additional 1,299 shares during the period. Mutual of America Capital Management LLC owned about 0.54% of Staar Surgical worth $1,547,000 as of its most recent filing with the SEC.

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.